| tooth cement | <dentistry> A bony substance covering the root of a tooth. (08 Jan 1998) |
|---|---|
| zinc oxide-eugenol cement | Least irritating of the cements. The powder is essentially zinc oxide with strengtheners and accelerators. The liquid is basically eugenol. (boucher's clinical dental terminology, 4th ed, p50) (12 Dec 1998) |
| zinc phosphate cement | <chemical> A material used for cementation of inlays, crowns, bridges, and orthodontic appliances and occasionally as a temporary restoration. It is prepared by mixing zinc oxide and magnesium oxide powders with a liquid consisting principally of phosphoric acid, water, and buffers. Chemical name: Phosphoric acid, zinc salt (2:3) (12 Dec 1998) |
| unmodified zinc oxide-eugenol cement | A dental cement obtained by mixing zinc oxide and eugenol without modifiers. (05 Mar 2000) |
| adhesion | 1. <chemistry> The property of remaining in close proximity, as that resulting from the physical attraction of molecules to a substance or the molecular attraction existing between the surfaces of contacting bodies. 2. The stable joining of parts to each other, which may occur abnormally. 3. A fibrous band or structure by which parts abnormally adhere. Origin: L. Adhaesio, from adhaerere = to stick to (15 Jan 1998) |
| adhesion dyspepsia | Pain, dyspepsia, and other symptoms alleged to result from perigastric adhesions. (05 Mar 2000) |
| adhesion molecules | Molecules that are involved in T helper-accessory cell, T helper-B-cell, and T cytotoxic-target cell interactions. (05 Mar 2000) |
| adhesion phenomenon | A phenomenon manifested by the adherence of antigen-antibody-complement complex to "indicator cells" (microorganisms, platelets, leukocytes, or erythrocytes), the reaction being sensitive and specific for the antigen and antibody in the complex. Synonym: erythrocyte adherence phenomenon, immune adherence phenomenon, red cell adherence phenomenon. (05 Mar 2000) |
| adhesion-related kinase | <chemical> New member of the immunoglobulin superfamily with 2 immunoglobulin-like domains Synonym: ark protein, ark receptor tyrosine kinase (26 Jun 1999) |
| adhesion structures linked tyrosine kinase | <enzyme> Isolated from mouse embryonic stem cells Registry number: EC 2.7.1.- Synonym: hyk protein (26 Jun 1999) |
| adhesion test | The diagnostic application of the immune adhesion phenomenon. Synonym: erythrocyte adherence test, immune adhesion test, red cell adherence test. (05 Mar 2000) |
| bacterial adhesion | Physicochemical property of fimbriated (fimbriae, bacterial) and non-fimbriated bacteria of attaching to cells, tissue, and nonbiological surfaces. It is a factor in bacterial colonization and pathogenicity. (12 Dec 1998) |
| vascular cell adhesion molecule-1 | Cytokine-induced cell adhesion molecule present on activated endothelial cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts, and myotubes. It is important for the recruitment of leukocytes to sites of inflammation. (12 Dec 1998) |
| receptors, leukocyte-adhesion | Family of proteins associated with the capacity of leukocytes, including lymphocytes, monocytes, and neutrophils, to adhere to each other and to certain substrata, e.g., the c3bi component of complement. Members of this family are the lymphocyte function-associated antigen-1 (lfa-1), the macrophage-1 antigen (mac-1), and the antigen p150,95 or p150,95 leukocyte adhesion protein. They all share a common beta-subunit which is the CD18 antigen. All three of the above antigens are absent in inherited leukocyte-adhesion deficiency syndrome, which is characterised by recurrent bacterial infections, impaired pus formation, and wound healing as well as abnormalities in a wide spectrum of adherence-dependent functions of granulocytes, monocytes, and lymphoid cells. (12 Dec 1998) |
| cell adhesion | See: adhesins, cadherins, cell adhesion molecules (CAMs), contact sites A, DLVO theory, integrins, sorting out, uvomorulin and various specialised junctions (adherens junctions, desmosomes, focal adhesions, gap junction and zonula occludens). (18 Nov 1997) |